March 6, 2025
UPDATE: DOGE quietly decreases savings estimate for 30 terminated FDA leases
Financial savings, United States Food and Drug Administration, DOGE, Estimated, leases, terminated – RoleStatus, St. Louis, DOGE ‘s
Patent Dispute Erupts Over Merck’s Injectable Keytruda
Merck, Halozyme, Keytruda, patent dispute, injectable cancer drug, enzyme technology
US judge blocks Trump administration from cutting NIH grants amid ongoing litigation
United States National Institutes of Health, Judge, injunction, implementing
Novo Nordisk looks into starting GLP-1 drug trials for addiction
Glucagon-Like Peptide 1, Addictive Behavior
ITM Reports Positive Phase 3 Data for Radiopharmaceutical ITM-11 in Neuroendocrine Tumors, Challenging Novartis’ Lutathera
ITM-11, radiopharmaceutical, Phase 3 COMPETE trial, neuroendocrine tumors, Lutathera, Novartis
Senators grill Trump’s NIH nominee on vaccines and funding
United States National Institutes of Health, Vaccines, Bhattacharya, Senators, Trump ‘s, Senators, research
TRIMTECH Therapeutics raises $31M seed funding to advance targeted protein degradation pipeline for treatment of neurodegenerative diseases
targeted protein degradation, neurodegenerative diseases, TRIM21, TRIMTAC degraders, CNS therapeutics, seed funding, biotech startup
Freed Raises $30M to Transform Medical Documentation with AI-Powered Assistant
AI medical scribe, clinician burnout, administrative burden, healthcare technology, Series A funding
Persica Reports Positive Phase 1b Results for Novel Antibiotic Treatment in Chronic Low Back Pain
Persica Pharmaceuticals, PP353, chronic low back pain, antibiotic therapy, Modic changes, Phase 1b clinical trial